Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency

Journal of Association of Physicians of India

Volumn 50, Issue 10, 2002, Pages 1245-1250

  Giri, S ^a   Mahajan, S K ^b   Sen, R ^b   Sharma, A ^b  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NIFEDIPINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MIDDLE AGED; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NIFEDIPINE; PROBABILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 11244253140     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Glassock RJ, Cohen AH, Adler SG. Primary glomerular disease. In: Brenner BM, editor. Brenner and Rectors'. The Kidney. 5th Ed. Philadelphia: WB Saunders Company, 1996;1392-1497.
2. Cotran RS, Kumar V, Collins T, editors. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders Company, 1999;930-6.
3. Fronhling PT, Krupki F, Kokot F, Vetter K, Kaschube I, Lindenau K. What are the most important factors in progression of renal failure. Kidney Int 1989;(Suppl)27:S106-9.
4. Nosrati SM, Khwaja S, el-Shahawy M, Massry SG. Effect of antiogensin converting enzyme inhibition by perindopril on proteinuria of primary renal diseases. Am J Nephrol 1997;17:511-7.
5. Smith RD, Rodel PV, Mulcahy WS, Price BA. Long-term renal effects of enalapril therapy in patients with renal insufficiency. Nephron 1990;55(suppl 1):49-58.
6. Radicio JL, Alcazar JM, Ruilope LM. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int 1990;38:590-4.
7. Mann JFE, Reisch C, Ritz E. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. Nephron 1990;55(Suppl 1):38-42.
8. Kamper AL, Strandgaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 1992;5:423-30.
9. Hannedouche T, Landais P, Goldfarb B, et al. Randomized controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ 1994;309:833-7.
10. Zucchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992;42:452-8.
11. Praga M, Hernandez E, Montoyo C, Andes A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992;20:240-8.
12. Peterson JC, Burkart J, Greene T, et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria at base-line evaluation. J Am Soc Nephrol 1993;4 Suppl:254A.
13. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996;334:946-51.
14. Tolins JP, Raij L. Angiotensin converting enzyme inhibitors and progression of chronic renal failure. Kidney Int 1990;38(Suppl 30):S118-22.
15. Gansevoort RT, Sluiter W, de Zeeuw D, de Jong PF. The antiproteinuric effect of angiotensin-converting enzyme inhibitor in comparison to that of other antihypertensives in diabetic and non-diabetic renal disease. J Am Soc Nephrol 1994;5 Suppl: 329A.
16. Dietz JR, Davis JO, Freeman RH, Villareal D, Echtenkamp SE. Effects of intrarenal infusion of calcium entry blockers in anaesthetized dogs. Hypertension 1983;5:482-8.